By

Webmaster
Photo of Dr. Emile Voest
Image courtesy of The Netherlands Cancer Institute Sanofi’s Board of Directors proposes the appointment of Emile Voest and two others as independent Directors. Emile Voest is one of MOSAIC TX’s founding advisors, currently serving as director of Cancer Core Europe– a collaboration of 7 leading cancer centres in Europe, and was Executive Medical Director of...
Dr. Mathew Garnett publishes a new resource to empower precision oncology
In a recent Nature paper (23 February, 2022) Dr. Mathew Garnett, and colleagues from the Wellcome Sanger Institute unveil the world’s largest novel resource of possible new drug combinations that could represent effective therapies for some types of hard-to-treat cancers. Scientists hope that this new data will help future clinical development of combination therapies, that...
We are very excited to welcome Jose, Adam, and James to our multidisciplinary team who have joined us recently and who will be instrumental in enhancing and guiding MOSAIC’s drug discovery activities. They bring with them a diverse mix of skills and will be applying innovative data science solutions to a range of drug discovery...
Help us change the odd on cancer
Cancer is a leading cause of death reducing life expectancy in every country of the world. According to estimates from the World Health Organization (WHO) in 2019, cancer is the first or second leading cause of death before the age of 70 years in 112 of 183 countries and ranks third or fourth in a further 23 countries....